Thank you, Madam Chair.
Welcome to everybody.
Mr. Yeates, it was said in the department's response that you are strengthening Health Canada's post-market surveillance for safety and effectiveness. How many post-market surveillance studies on individual drugs or devices are ongoing at the present moment and how many staff are doing the surveillance and the analysis?